ClinicalTrials HQ

First-in-Human Study of ICT01 in Patients With Advanced Cancer

First-in-Human Study of ICT01 in Patients With Advanced Cancer

Active, not recruiting · NCT04243499 · Registry updated 2026-09-04
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
First-in-Human Study of ICT01 in Patients With Advanced CancerHemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasmActive, not recruitingPhase 1 / Phase 22026-09-04NCT04243499

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
ImCheck Therapeutics, an Ipsen company1

29 results · Page 1 of 2

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Banner Md Anderson Cancer CenterGilbertUnited States121
Centre Antoine LacassagneNiceFrance83
Centre Hospitalier Lyon SudLyonFrance3
Centre Lyon BerardLyonFrance2
Chu LyonLyonFrance22
Chu NantesNantesFrance45
CHU PoitiersPoitiersFrance32
City of Hope Comprehensive Cancer CenterDuarteUnited States263
Gustave RoussyParisFrance5
H. Lee Moffitt Cancer Center and Research InstituteTampaUnited States32
Haut LevequeBordeauxFrance1
Hospital Universitario HM SanchinarroMadridSpain45
Institut BergonieBordeauxFrance23
Institut CurieParisFrance51
Institut Jules BordetBrusselsBelgium23
Institut Paoli-CalmettesMarseilleFrance23
Institute of Cancer ResearchLondonUnited Kingdom1
Montefiore Medical CenterThe BronxUnited States198
NHS Greater Glasgow and Clyde, Beatson West of Scotland Cancer CentreGlasgowUnited Kingdom1
Pitie-SalpetriereParisFrance1
START Barcelone HM Nou DelfosBarcelonaSpain1
START Madrid-FJD, Hospital Fundación Jiménez DíazMadridSpain1
The University of Texas MD Anderson Cancer CenterHoustonUnited States207
universitatklinikum WurburgWürzburgGermany1
University Carl Gustav Carus Clinical Trial UnitDresdenGermany1